Clinical Trials
4 trialsNCT06751524 2026-05-15
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus Inc.
Available
NCT04571229 2026-05-11
Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma
Memorial Sloan Kettering Cancer Center
Available
NCT05041036 2026-05-08
Individual Patient Compassionate Use of Nirogacestat
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Available
NCT06948955 2026-05-08
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Available